Octocog alfa

重组人凝血因子VIII（拜耳）

Report date: 2023/07/26 15:39:07

Base Information

Drug NameOctocog alfa
Drug Alias NameAntihemophilic Factor (Recombinant) (Bayer)Kogenate FSHelixate NexGenKovaltryKogenate +[9] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia ABlood Coagulation Disorders
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryUnited States
Original Approved Date1993/02/25
Country/TerritoryCzechiaBulgariaCanada +[38] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer Healthcare LlcBayer HealthcareBayer AG
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsBlood Coagulation Disorders

Other Information

ATC CodeB02BD02
Related LinksDrugBankKEGG